Consolidated Statements of Changes in Shareholders' Deficit - USD ($) $ in Thousands	Ordinary shares	Additional Paid in capital	Accumulated Deficit	Total Shareholders' Deficiency	Non- controlling interests	Total
Balance at Dec. 31, 2019	$ 2	$ 14,443	$ (25,100)	$ (10,655)		$ (10,655)
Balance (in Shares) at Dec. 31, 2019	2,054,539
Conversion of convertible loans	$ 1	276		277		277
Conversion of convertible loans (in Shares)	1,045,521
Share based compensation to non-employees		171		171		171
Share based compensation to non-employees (in Shares)	67,500
Beneficial conversion feature related to convertible loan		425		425		425
Issuance of warrants		94		94		94
Net Income (loss)			7,642	7,642		7,642
Balance at Dec. 31, 2020	$ 3	15,409	(17,458)	(2,046)		(2,046)
Balance (in Shares) at Dec. 31, 2020	3,167,560
Transactions with non-controlling parties		1,081		1,081	274	1,355
Receipt on account of shares in subsidiary		41		41	10	51
Share based compensation to non-controlling parties		566		566	144	710
Conversion of RSU’s
Conversion of RSU’s (in Shares)	13,025
Conversion of convertible loans	$ 1	830		831		831
Conversion of convertible loans (in Shares)	830,000
Share based compensation to non-employees		608		608		608
Share based compensation to non-employees (in Shares)	114,634
Exercise of options
Exercise of options (in Shares)	69,166
Issuance of warrants and convertible component		60		60		60
Net Income (loss)			(3,619)	(3,619)	(322)	(3,941)
Balance at Dec. 31, 2021	$ 4	$ 18,595	$ (21,077)	$ (2,478)	$ 106	$ (2,372)
Balance (in Shares) at Dec. 31, 2021	4,194,385